Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$18.60
+2.5%
$17.38
$8.92
$24.50
$842.58M1.69408,677 shs241,675 shs
Cutera, Inc. stock logo
CUTR
Cutera
$2.75
-3.8%
$1.98
$1.28
$21.41
$54.84M1.431.57 million shs1.16 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$127.28
-4.0%
$86.63
$36.42
$132.96
$4.19B1.87770,703 shs916,001 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+0.67%+1.62%+5.95%+0.33%-6.15%
Cutera, Inc. stock logo
CUTR
Cutera
+13.04%+21.70%+83.33%+2.88%-86.06%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+3.64%+36.40%+55.99%+53.03%+79.21%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.2981 of 5 stars
3.52.00.00.02.22.50.6
Cutera, Inc. stock logo
CUTR
Cutera
1.0397 of 5 stars
3.31.00.00.01.11.70.6
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.2184 of 5 stars
2.41.00.00.03.62.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$23.4025.81% Upside
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$14.75436.36% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.88
Moderate Buy$119.00-6.51% Downside

Current Analyst Ratings

Latest TMDX, BLFS, and CUTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$100.00 ➝ $130.00
5/1/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$102.00 ➝ $117.00
5/1/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$105.00 ➝ $127.00
5/1/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$95.00 ➝ $120.00
5/1/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$105.00 ➝ $125.00
4/4/2024
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$22.00
3/28/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$95.00
3/22/2024
Cutera, Inc. stock logo
CUTR
Cutera
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
3/22/2024
Cutera, Inc. stock logo
CUTR
Cutera
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Market Perform
3/6/2024
Cutera, Inc. stock logo
CUTR
Cutera
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
2/28/2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $95.00
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$143.27M5.88N/AN/A$7.67 per share2.43
Cutera, Inc. stock logo
CUTR
Cutera
$212.37M0.26N/AN/A($8.01) per share-0.34
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$241.62M17.35$0.14 per share899.20$4.20 per share30.30

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$66.43M-$1.52N/AN/AN/A-46.37%-13.36%-10.83%5/9/2024 (Confirmed)
Cutera, Inc. stock logo
CUTR
Cutera
-$150.83M-$7.34N/AN/AN/A-68.87%N/A-34.04%5/9/2024 (Confirmed)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$25.03M-$0.34N/A131.22N/A-3.43%7.95%1.61%8/1/2024 (Estimated)

Latest TMDX, BLFS, and CUTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.25N/A+$0.25N/AN/AN/A  
5/9/2024N/A
Cutera, Inc. stock logo
CUTR
Cutera
-$1.09N/A+$1.09N/AN/AN/A  
4/30/2024Q1 2024
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$0.05$0.35+$0.40$0.35$83.78 million$96.90 million    
3/21/2024Q4 2023
Cutera, Inc. stock logo
CUTR
Cutera
-$1.20-$2.27-$1.07-$2.27$49.10 million$49.54 million
3/5/2024Q3 2023
Cutera, Inc. stock logo
CUTR
Cutera
N/A-$2.22-$2.22-$2.22N/A$46.48 million
2/29/2024Q4 2023
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.24-$0.22+$0.02-$0.14$32.70 million$32.73 million
2/26/2024Q4 2023
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$0.10$0.12+$0.22$0.12$68.49 million$81.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.06
2.86
1.83
Cutera, Inc. stock logo
CUTR
Cutera
N/A
3.17
2.44
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
3.18
9.72
8.76

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.70%
Cutera, Inc. stock logo
CUTR
Cutera
2.90%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
7.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
40945.30 million44.08 millionOptionable
Cutera, Inc. stock logo
CUTR
Cutera
54019.94 million19.37 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
58432.94 million30.63 millionOptionable

TMDX, BLFS, and CUTR Headlines

SourceHeadline
TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $132.96TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $132.96
marketbeat.com - May 7 at 1:14 PM
Lisanti Capital Growth LLC Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX)Lisanti Capital Growth LLC Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - May 6 at 10:13 PM
Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?
zacks.com - May 6 at 10:01 AM
TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
seekingalpha.com - May 6 at 12:21 AM
TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call TranscriptTransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 5 at 6:46 PM
Tamer I. Khayal Sells 63,260 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockTamer I. Khayal Sells 63,260 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) Stock
americanbankingnews.com - May 5 at 5:52 AM
Waleed H. Hassanein Sells 56,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockWaleed H. Hassanein Sells 56,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) Stock
americanbankingnews.com - May 5 at 5:52 AM
James R. Tobin Sells 15,040 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockJames R. Tobin Sells 15,040 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) Stock
americanbankingnews.com - May 5 at 5:10 AM
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 15,040 Shares of StockInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 15,040 Shares of Stock
insidertrades.com - May 4 at 7:32 AM
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 56,000 Shares of StockInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 56,000 Shares of Stock
insidertrades.com - May 4 at 7:27 AM
JPMorgan Chase & Co. Raises TransMedics Group (NASDAQ:TMDX) Price Target to $127.00JPMorgan Chase & Co. Raises TransMedics Group (NASDAQ:TMDX) Price Target to $127.00
americanbankingnews.com - May 4 at 5:18 AM
TransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Piper SandlerTransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Piper Sandler
americanbankingnews.com - May 4 at 5:18 AM
New York State Common Retirement Fund Increases Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)New York State Common Retirement Fund Increases Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - May 4 at 5:18 AM
TransMedics Group, Inc. to Post Q2 2024 Earnings of $0.10 Per Share, William Blair Forecasts (NASDAQ:TMDX)TransMedics Group, Inc. to Post Q2 2024 Earnings of $0.10 Per Share, William Blair Forecasts (NASDAQ:TMDX)
americanbankingnews.com - May 4 at 1:43 AM
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
zacks.com - May 3 at 1:21 PM
TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?
zacks.com - May 3 at 10:16 AM
TransMedics Group First Quarter 2024 Earnings: Beats ExpectationsTransMedics Group First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 3 at 8:31 AM
Should You Think About Buying TransMedics Group, Inc. (NASDAQ:TMDX) Now?Should You Think About Buying TransMedics Group, Inc. (NASDAQ:TMDX) Now?
finance.yahoo.com - May 3 at 8:31 AM
William Blair Analysts Increase Earnings Estimates for TransMedics Group, Inc. (NASDAQ:TMDX)William Blair Analysts Increase Earnings Estimates for TransMedics Group, Inc. (NASDAQ:TMDX)
marketbeat.com - May 3 at 7:28 AM
TransMedics Group (NASDAQ:TMDX) PT Raised to $125.00TransMedics Group (NASDAQ:TMDX) PT Raised to $125.00
americanbankingnews.com - May 3 at 6:42 AM
TransMedics Group (NASDAQ:TMDX) PT Raised to $117.00 at Canaccord Genuity GroupTransMedics Group (NASDAQ:TMDX) PT Raised to $117.00 at Canaccord Genuity Group
americanbankingnews.com - May 3 at 5:18 AM
William Blair Weighs in on TransMedics Group, Inc.s Q3 2025 Earnings (NASDAQ:TMDX)William Blair Weighs in on TransMedics Group, Inc.'s Q3 2025 Earnings (NASDAQ:TMDX)
americanbankingnews.com - May 3 at 4:00 AM
Is TransMedics (TMDX) a Buy as Wall Street Analysts Look Optimistic?Is TransMedics (TMDX) a Buy as Wall Street Analysts Look Optimistic?
zacks.com - May 2 at 10:31 AM
TransMedics Group, Inc. (NASDAQ:TMDX) to Post Q3 2025 Earnings of $0.12 Per Share, William Blair ForecastsTransMedics Group, Inc. (NASDAQ:TMDX) to Post Q3 2025 Earnings of $0.12 Per Share, William Blair Forecasts
marketbeat.com - May 2 at 8:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BioLife Solutions logo

BioLife Solutions

NASDAQ:BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Cutera logo

Cutera

NASDAQ:CUTR
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
TransMedics Group logo

TransMedics Group

NASDAQ:TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.